- £3.00bn
- £3.14bn
- £1.93bn
- 55
- 14
- 56
- 33
Annual income statement for Qinetiq, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,278 | 1,320 | 1,581 | 1,912 | 1,932 |
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,159 | 1,193 | 1,382 | 1,714 | 2,021 |
| Operating Profit | 119 | 127 | 199 | 198 | -89.5 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 146 | 126 | 192 | 183 | -106 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 125 | 90 | 154 | 140 | -186 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 125 | 90 | 154 | 140 | -186 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 125 | 90 | 154 | 140 | -186 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.208 | 0.145 | 0.233 | 0.295 | 0.117 |
| Dividends per Share |